» Articles » PMID: 20452969

Pregnenolone Sulfate and Cortisol Induce Secretion of Acyl-CoA-binding Protein and Its Conversion into Endozepines from Astrocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 May 11
PMID 20452969
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Acyl-CoA-binding protein (ACBP) functions both intracellularly as part of fatty acid metabolism and extracellularly as diazepam binding inhibitor, the precursor of endozepine peptides. Two of these peptides, ODN and TTN, bind to the GABA(A) receptor and modulate its sensitivity to gamma-aminobutyric acid (GABA). We have found that depolarization of mouse primary astrocytes induces the rapid release and processing of ACBP to the active peptides. We previously showed that ODN can trigger the rapid sporulation of the social amoeba Dictyostelium. Using this bioassay, we now show that astrocytes release the endozepine peptides within 10 min of exposure to the steroids cortisol, pregnenolone, pregnenolone sulfate, or progesterone. ACBP lacks a signal sequence for secretion through the endoplasmic reticulum/Golgi pathway and its secretion is not affected by addition of brefeldin A, a well known inhibitor of the classical secretion pathway, suggesting that it follows an unconventional pathway for secretion. Moreover, induction of autophagy by addition of rapamycin also resulted in rapid release of ACBP indicating that this protein uses components of the autophagy pathway for secretion. Following secretion, ACBP is proteolytically cleaved to the active neuropeptides by protease activity on the surface of astrocytes. Neurosteroids, such as pregnenolone sulfate, were previously shown to modulate the excitatory/inhibitory balance in brain through increased release of glutamate and decreased release of GABA. These effects of steroids in neurons will be reinforced by the release of endozepines from astrocytes shown here, and suggest an orchestrated astrocyte-neuron cross-talk that can affect a broad spectrum of behavioral functions.

Citing Articles

Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouse.

Li S, Mingoia S, Montegut L, Lambertucci F, Chen H, Dong Y Cell Death Dis. 2025; 16(1):134.

PMID: 40011442 PMC: 11865319. DOI: 10.1038/s41419-025-07447-w.


Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity.

Isnard S, Mabanga T, Royston L, Berini C, Bu S, Aiyana O Front Immunol. 2025; 15():1505752.

PMID: 39835130 PMC: 11743960. DOI: 10.3389/fimmu.2024.1505752.


Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing's syndrome.

Pan H, Tian A, Chen H, Xia Y, Sauvat A, Moriceau S Nat Metab. 2024; 6(12):2281-2299.

PMID: 39578649 PMC: 11659162. DOI: 10.1038/s42255-024-01170-0.


Acyl coenzyme A binding protein (ACBP): An aging- and disease-relevant "autophagy checkpoint".

Montegut L, Abdellatif M, Motino O, Madeo F, Martins I, Quesada V Aging Cell. 2023; 22(9):e13910.

PMID: 37357988 PMC: 10497816. DOI: 10.1111/acel.13910.


High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP.

Montegut L, Joseph A, Chen H, Abdellatif M, Ruckenstuhl C, Motino O Aging Cell. 2022; 22(1):e13751.

PMID: 36510662 PMC: 9835587. DOI: 10.1111/acel.13751.


References
1.
Faergeman N, Wadum M, Feddersen S, Burton M, Kragelund B, Knudsen J . Acyl-CoA binding proteins; structural and functional conservation over 2000 MYA. Mol Cell Biochem. 2006; 299(1-2):55-65. DOI: 10.1007/s11010-005-9040-3. View

2.
Anjard C, Loomis W . Peptide signaling during terminal differentiation of Dictyostelium. Proc Natl Acad Sci U S A. 2005; 102(21):7607-11. PMC: 1140433. DOI: 10.1073/pnas.0501820102. View

3.
Knecht D, Loomis W . Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum. Science. 1987; 236(4805):1081-6. DOI: 10.1126/science.3576221. View

4.
Memmott R, Dennis P . Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal. 2009; 21(5):656-64. PMC: 2650010. DOI: 10.1016/j.cellsig.2009.01.004. View

5.
Kinney J, Davis C, Tabarean I, Conti B, Bartfai T, Margarita Behrens M . A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci. 2006; 26(5):1604-15. PMC: 6675509. DOI: 10.1523/JNEUROSCI.4722-05.2006. View